Innate Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	53.7	66.4	70.61	84.23	103.76	136.79
Short-Term Investments	6.32	14.37	21.85	17.26	16.08	14.85
Cash & Short-Term Investments	60.03	80.77	92.46	101.49	119.84	151.64
Cash Growth	-34.61%	-12.64%	-8.90%	-15.31%	-20.97%	-30.72%
Accounts Receivable	4.95	4.97	55.56	38.35	18.42	21.81
Total Current Assets	64.98	85.74	148.01	139.83	138.26	173.45
Net Property, Plant & Equipment	4.96	5.13	6.32	8.54	10.17	11.69
Other Intangible Assets	-	-	0.42	1.56	44.19	46.29
Long-Term Investments	10.39	10.28	9.8	35.12	39.88	38.93
Other Long-Term Assets	12.61	9.9	10.64	14.25	35	37.06
Total Assets	92.94	111.06	175.19	199.3	267.5	307.42
Accounts Payable	12.04	16.01	17.02	20.91	28.57	29.54
Short-Term Debt	8.93	8.71	8.94	2.1	30.75	2.14
Unearned Revenue	44.49	52.01	63.16	77.69	78.33	90.66
Other Current Liabilities	1.11	0.21	0.17	1.54	0.65	0.68
Total Current Liabilities	29.43	32.98	39.64	41.34	79.89	45.49
Long-Term Debt	18.1	22.29	30.96	40.15	13.5	16.95
Other Long-Term Liabilities	3.13	3	3.04	2.75	8.26	11.49
Total Long-Term Liabilities	58.37	69.24	83.65	103.81	80.17	105.96
Total Liabilities	87.79	102.23	123.29	145.14	160.06	151.45
Common Stock	4.61	4.19	4.04	4.01	3.98	3.95
Additional Paid-in Capital	407.05	390.98	384.26	379.64	375.22	372.13
Accumulated Other Comprehensive Income	1.19	0.03	0.5	0.82	0.46	0.36
Retained Earnings	-407.71	-386.36	-336.89	-330.32	-272.21	-220.46
Shareholders' Equity	5.14	8.83	51.9	54.15	107.44	155.98
Total Liabilities & Equity	92.94	111.06	175.19	199.3	267.5	307.42
Total Debt	27.03	31	39.89	42.25	44.25	19.09
Net Cash (Debt)	33	49.78	52.56	59.23	75.59	132.55
Net Cash Growth	-33.71%	-5.30%	-11.26%	-21.63%	-42.98%	-33.77%
Net Cash Per Share	0.39	0.61	0.65	-	0.96	1.68
Book Value	5.14	8.83	51.9	54.15	107.44	155.98
Book Value Per Share	0.06	0.11	0.65	-	1.36	1.98
Tangible Book Value	5.14	8.83	51.49	52.6	63.25	109.69
Tangible Book Value Per Share	0.06	0.11	0.64	-	0.80	1.39

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q